Literature DB >> 11470050

The clinical laboratory evaluation of the patient with noninflammatory myopathy.

R L Wortmann1, G D Vladutiu.   

Abstract

The investigations used to diagnose an inflammatory muscle disease include history and physical examination, evaluation of serum levels of enzymes derived from skeletal muscle, electromyography, magnetic resonance imaging, and muscle histology. The evaluation of patients who may have noninflammatory myopathy includes, but is not limited to, these methods. Additional tools that may be useful include measurements of additional biochemistries, the forearm ischemic exercise test, magnetic resonance spectroscopy, and special tests on muscle tissue. Reports published in the past year have improved and expanded our understanding of the numerous noninflammatory myopathies and how these tools can be used more effectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470050     DOI: 10.1007/s11926-001-0035-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  21 in total

Review 1.  Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways.

Authors:  J Vockley; P Rinaldo; M J Bennett; D Matern; G D Vladutiu
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

2.  Magnetic resonance imaging of denervated muscle: comparison to electromyography.

Authors:  C M McDonald; G T Carter; R C Fritz; M W Anderson; R T Abresch; D D Kilmer
Journal:  Muscle Nerve       Date:  2000-09       Impact factor: 3.217

Review 3.  The molecular diagnosis of metabolic myopathies.

Authors:  G D Vladutiu
Journal:  Neurol Clin       Date:  2000-02       Impact factor: 3.806

4.  A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle's disease.

Authors:  J C Rubio; M A Martín; Y Campos; R Auciello; A Cabello; J Arenas
Journal:  Muscle Nerve       Date:  2000-01       Impact factor: 3.217

5.  Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.

Authors:  M A Tarnopolsky; G Parise
Journal:  Muscle Nerve       Date:  1999-09       Impact factor: 3.217

6.  A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.

Authors:  G D Vladutiu; M J Bennett; D Smail; L J Wong; R T Taggart; H B Lindsley
Journal:  Mol Genet Metab       Date:  2000-06       Impact factor: 4.797

Review 7.  Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment.

Authors:  R Subramanian; R Khardori
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

8.  Congenital and metabolic myopathies of childhood or adult onset.

Authors:  O Miró; M Laguno; F Masanés; M Perea; A Urbano-Márquez; J M Grau
Journal:  Semin Arthritis Rheum       Date:  2000-06       Impact factor: 5.532

Review 9.  Applications of NMR spectroscopy to study muscle glycogen metabolism in man.

Authors:  M Roden; G I Shulman
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

Review 10.  Mitochondrial disorders: clinical and genetic features.

Authors:  D K Simon; D R Johns
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

View more
  1 in total

1.  Polymyositis-like syndrome caused by hypothyroidism, presenting as camptocormia.

Authors:  Ji Min Kim; Eun Joo Song; Jae Seok Seo; Eon Jeong Nam; Young Mo Kang
Journal:  Rheumatol Int       Date:  2008-08-19       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.